Beijing Restricts Cold Drug Sales To Restrict Ephedrine Use
This article was originally published in PharmAsia News
Beijing pharmacies are being used to crack down on illegal use of ephedrine by restricting the purchase of 30 types of common cold medicines containing the ingredient. The new local regulation restricts purchases to just five boxes or bottles per visit, enough for a week. China's State FDA notified pharmacies that police authorities were finding the ephedrine in the medicines was being used to make the recreational drug "ice" in some parts of the country. (Click here for more
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.